Logo image of AXTI

AXT INC (AXTI) Stock Fundamental Analysis

NASDAQ:AXTI - Nasdaq - US00246W1036 - Common Stock - Currency: USD

2.35  +0.37 (+18.69%)

Premarket: 2.28 -0.07 (-2.98%)

Fundamental Rating

2

AXTI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. AXTI has a bad profitability rating. Also its financial health evaluation is rather negative. AXTI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AXTI had negative earnings in the past year.
AXTI had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AXTI reported negative net income in multiple years.
In multiple years AXTI reported negative operating cash flow during the last 5 years.
AXTI Yearly Net Income VS EBIT VS OCF VS FCFAXTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -5.55%, AXTI is not doing good in the industry: 69.09% of the companies in the same industry are doing better.
With a Return On Equity value of -10.01%, AXTI is not doing good in the industry: 67.27% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.55%
ROE -10.01%
ROIC N/A
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
AXTI Yearly ROA, ROE, ROICAXTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

With a Gross Margin value of 17.18%, AXTI is not doing good in the industry: 83.64% of the companies in the same industry are doing better.
AXTI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AXTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
AXTI Yearly Profit, Operating, Gross MarginsAXTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AXTI has more shares outstanding
Compared to 5 years ago, AXTI has more shares outstanding
AXTI has a worse debt/assets ratio than last year.
AXTI Yearly Shares OutstandingAXTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AXTI Yearly Total Debt VS Total AssetsAXTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

AXTI has an Altman-Z score of 0.55. This is a bad value and indicates that AXTI is not financially healthy and even has some risk of bankruptcy.
AXTI's Altman-Z score of 0.55 is on the low side compared to the rest of the industry. AXTI is outperformed by 72.73% of its industry peers.
AXTI has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
AXTI's Debt to Equity ratio of 0.31 is on the low side compared to the rest of the industry. AXTI is outperformed by 62.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 0.55
ROIC/WACCN/A
WACC10.28%
AXTI Yearly LT Debt VS Equity VS FCFAXTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.99 indicates that AXTI should not have too much problems paying its short term obligations.
AXTI's Current ratio of 1.99 is on the low side compared to the rest of the industry. AXTI is outperformed by 76.36% of its industry peers.
AXTI has a Quick Ratio of 1.99. This is a bad value and indicates that AXTI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.92, AXTI is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 0.92
AXTI Yearly Current Assets VS Current LiabilitesAXTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.50% over the past year.
The Revenue has grown by 21.42% in the past year. This is a very strong growth!
AXTI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.59% yearly.
EPS 1Y (TTM)2.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)21.42%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%-14.69%

3.2 Future

The Earnings Per Share is expected to grow by 35.67% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.33% on average over the next years. This is quite good.
EPS Next Y-108.25%
EPS Next 2Y35.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.01%
Revenue Next 2Y9.33%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AXTI Yearly Revenue VS EstimatesAXTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
AXTI Yearly EPS VS EstimatesAXTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AXTI. In the last year negative earnings were reported.
Also next year AXTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AXTI Price Earnings VS Forward Price EarningsAXTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXTI Per share dataAXTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as AXTI's earnings are expected to grow with 35.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.67%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AXTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXT INC

NASDAQ:AXTI (6/12/2025, 8:00:01 PM)

Premarket: 2.28 -0.07 (-2.98%)

2.35

+0.37 (+18.69%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners47.36%
Inst Owner Change-27.2%
Ins Owners2.21%
Ins Owner Change12.54%
Market Cap107.16M
Analysts83.64
Price Target3.93 (67.23%)
Short Float %2.09%
Short Ratio2.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-86.8%
Min EPS beat(2)-130.68%
Max EPS beat(2)-42.91%
EPS beat(4)2
Avg EPS beat(4)-29.68%
Min EPS beat(4)-130.68%
Max EPS beat(4)32.39%
EPS beat(8)5
Avg EPS beat(8)-5.53%
EPS beat(12)9
Avg EPS beat(12)11.41%
EPS beat(16)12
Avg EPS beat(16)11.13%
Revenue beat(2)1
Avg Revenue beat(2)1.4%
Min Revenue beat(2)-0.03%
Max Revenue beat(2)2.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.99%
Min Revenue beat(4)-10.79%
Max Revenue beat(4)4.02%
Revenue beat(8)4
Avg Revenue beat(8)-0.16%
Revenue beat(12)4
Avg Revenue beat(12)-1.81%
Revenue beat(16)6
Avg Revenue beat(16)-0.95%
PT rev (1m)0%
PT rev (3m)-23%
EPS NQ rev (1m)-31.37%
EPS NQ rev (3m)-129.45%
EPS NY rev (1m)-118.17%
EPS NY rev (3m)-775%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.12
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS2.11
BVpS4.06
TBVpS4.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.55%
ROE -10.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.18%
FCFM N/A
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.97%
Cap/Sales 1.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 0.92
Altman-Z 0.55
F-Score3
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)178.33%
Cap/Depr(5y)282.49%
Cap/Sales(3y)13.27%
Cap/Sales(5y)16.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-108.25%
EPS Next 2Y35.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.42%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%-14.69%
Revenue Next Year-6.01%
Revenue Next 2Y9.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-85.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-378.56%
OCF growth 3YN/A
OCF growth 5YN/A